Effect of crystallization inhibitors on vascular calcifications induced by vitamin D - A pilot study in Sprague-Dawley rats

Circulation Journal

Volumn 71, Issue 7, 2007, Pages 1152-1156

  Grases, Félix ^a   Sanchis, Pilar ^a   Perelló, Joan ^a   Isern, Bernat ^a   Prieto, Rafel M ^a   Fernández Palomeque, Carlos ^b   Torres, José J ^b  

^a UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^b HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Crystallization inhibitors; Etidronate; Phytate; Vascular calcification; Vitamin D

Indexed keywords

CALCIUM; ETIDRONIC ACID; PHYTATE; PLACEBO; VITAMIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL CALCIFICATION; CALCINOSIS; CONTROLLED STUDY; CRYSTALLIZATION; DRUG EFFECT; HEART; HISTOLOGY; MALE; NONHUMAN; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; AORTA; ATHEROSCLEROSIS; BONE DENSITY CONSERVATION AGENTS; CALCINOSIS; CALCIUM; CRYSTALLIZATION; ETIDRONIC ACID; MALE; MYOCARDIUM; PHYTIC ACID; PILOT PROJECTS; POLYPHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN D;

EID: 34347212086     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.1152     Document Type: Article

References (49)

1. Beadenkopf WG, Daoud AS, Love BM. Calcification in the coronary arteries and its relationship to arteriosclerosis and myocardial infarction. Am J Roentgenol Radium Ther Nucl Med 1964; 92: 865-871.
2. Loecker TH, Schwartz RS, Cotta CW, Hickman JR Jr. Fluoroscopic coronary artery calcification and associated coronary disease in asymptomatic young men. J Am Coll Cardiol 1992; 19: 1167-1172.
3. Wong ND, Detrano RC, Abrahamson D, Tobis JM, Gardin JM. Coronary artery screening by electron beam computed tomography: Facts, controversy, and future. Circulation 1995; 92: 632-636.
4. O'Keefe JH Jr, Lavie CJ, Nishimura RA, Edwards WD. Degenerative aortic stenosis: One effect of the graying of America. Postgrad Med 1991; 89: 143-146, 151-154.
5. Kim SC, Coe FL, Tinmouth WW, Kuo RL, Paterson RF, Parks JH, et al. Stone formation is proportional to papillary surface coverage by Randall's plaque. J Urol 2005; 173: 117-119.
6. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 1998; 31: 607-617.
7. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 2006; 21: 484-490.
8. Redey SA, Razzouk S, Rey C, Bernache-Assollant D, Leroy G, Nardin M, et al. Osteoclast adhesion and activity on synthetic hydroxyapatite, carbonated hydroxyapatite, and natural calcium carbonate: Relationship to surface energies. J Biomed Mater Res 1999; 45: 140-147.
9. Shen M, Marie P, Farge D, Carpentier S, De Pollak C, Hott M, et al. Osteopontin is associated with bioprosthetic heart valve calcification in humans. C R Acad Sci III 1997; 320: 49-57.
10. Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-1696.
11. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, et al. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995; 92: 2163-2168.
12. Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin: A possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 1990; 87: 4473-4475.
13. Yoshitake H, Rittling SR, Denhardt DT, Noda M. Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption. Proc Natl Acad Sci USA 1999; 96: 8156-8160.
14. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 1998; 12: 1260-1268.
15. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, et al. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309-319.
16. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 1998; 139: 1329-1337.
17. Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81.
18. Price PA, Faus SA, Williamson MK. Warfarin causes rapid calcification of the elastic lamellae in rat arteries and heart valves. Arterioscler Thromb Vasc Biol 1998; 18: 1400-1407.
19. Zebboudj AF, Imura M, Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002; 277: 4388-4394.
20. Levy RJ, Schoen FJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983; 113: 143-155.
21. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW. Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 1993; 22: 147-159.
22. Hunter GK, Goldberg HA. Nucleation of hydroxyapatite by bone sialoprotein. Proc Natl Acad Sci USA 1993; 90: 8562-8565.
23. Hunter GK, Haushka PV, Poole AR, Rosenberg LC, Goldberg HA. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996; 317: 59-64.
24. Govindaraj A, Selvam R. An oxalate-binding protein with crystal growth promoter activity from human kidney stone matrix. BJU Int 2002; 90: 336-344.
25. Lieske JC, Toback FG, Deganello S. Sialic acid-containing glycoproteins on renal cells determine nucleation of calcium oxalate dihydrate crystals. Kidney Int 2001; 60: 1784-1791.
26. Yamate T, Kohri K, Umekawa T, Amasaki N, Amasaki N, Isikawa Y, et al. The effect of osteopontin on the adhesion of calcium oxalate crystals to Madin-Darby canine kidney cells. Eur Urol 1996; 30: 388-393.
27. Ruoslahti E, Obrink B. Common principles in cell adhesion. Exp Cell Res 1996; 227: 1-11.
28. Lomashvili KA, Cobbs S, Hennigar RA, Hardcastle KI, O'Neill WC. Phosphate-induced vascular calcification: Role of pyrophosphate and osteopontin. J Am Soc Nephrol 2004; 15: 1392-1401.
29. Bevilacqua M, Dominguez LJ, Rosini S, Barbagallo M. Bisphosphonates and atherosclerosis: Why? Lupus 2005; 14: 773-779.
30. Price PA, Faus SA, Williamson MK. Bisphosphonates alendronate and ibandronate inhibit artery calcification at doses comparable to those that inhibit bone resorption. Arterioscler Thromb Vasc Biol 2001; 21: 817-824.
31. Price PA, Buckley JR, Williamson MK. The amino bisphosphonate ibandronate prevents vitamin D toxicity and inhibits vitamin D-induced calcification of arteries, cartilage, lungs and kidneys in rats. J Nutr 2001; 131: 2910-2915.
32. Grases F, Sanchis P, Perello J, Isern B, Prieto RM, Fernandez-Palomeque C, et al. Phytate (myo-inositol hexakisphosphate) inhibits cardiovascular calcifications in rats. Front Biosci 2006; 11: 136-142.
33. Francis RM. Bisphosphonates in the treatment of osteoporosis in 1997: A review. Curr Ther Res Clin Exp 1997; 58: 656-678.
34. 6 levels in tissues and biological fluids depending on dietary phytate. J Nutr Biochem 2001; 12: 595-601.
35. 6 or phytate) in humans. Biofactors 2001; 15: 53-61.
36. Grases F, Perello J, Isern B, Prieto RM. Study of a myo-inositol hexaphosphate-based cream to prevent dystrophic calcinosis cutis. Br J Dermatol 2005; 152: 1022-1025.
37. Coburn JW, Barbour GL. Vitamin D intoxication and sarcoidosis. In: Coe FL, editor. Hypercalciuric states: Pathogenesis, consequences and treatment. Orlando, Grune and Stratton; 1984; 379-406.
38. Pettifor JM, Bikle DD, Cavaleros M, Zachen D, Kamdar MC, Ross FP. Serum levels of free 1,25-dihydroxyvitamin D in vitamin D toxicity. Ann Intern Med 1995; 122: 511-513.
39. Stern PH, Bell NH. Disorders of vitamin D metabolism: Toxicity and hypersensitivity. In: Tam CS, Heersche JNM, Murrat TM, editors. Metabolic bone disease: Cellular and tissue mechanism. Boca Raton: CRC Press; 1989; 203-213.
40. Grases F, Costa-Bauza A, Konigsberger E, Konigsberger LC. Kinetic versus thermodynamic factors in calcium renal lithiasis. Int Urol Nephrol 2000; 32: 19-27.
41. Grases F, Ramis M, Costa-Bauza A. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization: Comparison with the action of other polyphosphates. Urol Res 2000; 28: 136-140.
42. Grases F, Simonet BM, Prieto RM, March JG. Phytate levels in diverse rat tissues: Influence of dietary phytate. Br J Nutr 2001; 86: 225-231.
43. Grases F, Simonet BM, Perello J, Costa-Bauza A, Prieto RM. Effect of phytate on element bioavailability in the second generation of rats. J Trace Elem Med 2004; 17: 229-234.
44. Ichikawa H, Ohishi S, Takahashi O, Kobayashi H, Yuzawa K, Hosokawa N, et al. Acute oral toxicities of phytic acid and sodium phytate in rats. Kenkyu Nenpo-Tokyo-toritsu Eisei Kenkyusho 1987; 38: 371-376.
45. Najman S, Dordevic Lj, Savic V, Ignjatovic N, Plavsic M, Uskokovic D. Changes of HAp/PLLA biocomposites and tissue reaction after subcutaneous implantation. Facta Universitatis 2003; 10: 131-134.
46. Nadra I, Mason JC, Philippidis P, Florey O, Smythe CDW, McCarthy GM, et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: A vicious cycle of inflammation and arterial calcification? Circ Res 2005; 96: 1248-1256.
47. Sun YB, Zeng XR, Wenger L, Cheung HS. Basic calcium phosphate crystals stimulate the endocytotic activity of cells-inhibition by anti-calcification agents. Biochem Biophys Res Commun 2003; 312: 1053-1059.
48. Grases F, Prieto RM, Simonet BM, March JG. Phytate prevents tissue calcifications in female rats. Biofactors 2000; 11: 171-177.
49. Grases F, Perello J, Prieto RM, Simonet BM, Torres JJ. Dietary myoinositol hexaphosphate prevents dystrophic calcifications in soft tissues: A pilot study in Wistar rats. Life Sci 2004; 75: 11-19.